BioRem OverviewLatest common stock for BIRMF: $5.3M.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for BIRMF is $5.3M as of June 2026. That compares with $5.2M in the prior-year period — up 1.6% year over year. Investors often review this figure alongside BioRem's historical trend and sector peers before judging valuation or financial health.
Over the past year, BIRMF's common stock moved from $5.2M to $5.3M — a 1.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioRem's operating scale or balance-sheet position.
A common stock figure of $5.3M for BIRMF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting BIRMF's common stock ($5.3M), review year-over-year change from $5.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
